Nine in 10 Americans use AI on their phone — but only 38% actually realize that they do. A survey of 2,000 adults explored ...
A researcher and writer has highlighted some major claims she's seen over the effects of weight loss supplements, which ...
A researcher has highlighted a variety claims made by weight loss supplement sellers and how 'egregious' some of them can be ...
Search engines transformed health information access, and LLMs offer a new avenue for answering laypeople’s questions. Objective: We aimed to compare the frequency of use and attitudes toward LLMs and ...
After 10 days with only the open ocean and the occasional iceberg at our sides, sailing into the sea ice felt like crossing ...
The interconnection of the world’s knowledge was expected to democratize education. Instead, it has democratized ...
UBS said that its recent Enterprise AI survey results continue to point to Microsoft (MSFT), OpenAI (OPENAI), and Nvidia (NVDA) as key AI winners, with Google (GOOGL) showing strong progress at the ...
Sanofi is scrapping plans to get one of its more advanced experimental medicines approved for a certain kind of multiple sclerosis, following negative results from a clinical trial disclosed Monday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback